Health ministry asks NMC to reconsider its RMP regulations over generic medicines issue: Report

Published On 2023-08-24 12:30 GMT   |   Update On 2023-08-24 12:30 GMT

Prescribing generic clause is likely to lose its teeth as the Union Health Ministry has now written to the National Medical Commission (NMC) to modify the recent National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023, a recent media report by The Print has stated.

Sources in the Union Health Ministry informed The Print that the Apex Medical Commission has been asked to make changes in the regulations on various issues, including the clause involving generic drugs and the Ministry has reportedly asked the Commission to allow the doctors to at least prescribe branded medicines.

For more details, check out the link given below:

Health Ministry Asks NMC To Reconsider Its RMP Regulations Over Generic Medicines Issue: Report

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News